Prospective Clinical Evaluation of Three Prosthesis Re-cap, M2a-Magnum and C2a-taper.

This evaluation is being conducted to evaluate the performance of thee prosthesis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patients Undergoing a THR

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Frederiksberg University Hospital

Copenhagen, Frederiksberg, 2000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Good general health of age (ASA I-II)
DEXA-scanning: lower limit for a 55 years old man
MRI normal vitality in caput
Willing to return for follow-up evaluations
Exclusion Criteria:
Subjects displaying any of the following contra-indications shall be excluded from this evaluation:
Inability to co-operate with and complete the study
Collum < 2 cm
Large cysts in caput
Mismatch between caput acetabulum
Caput necrosis

Treatment and study plan

Hip prosthesis (re-cap, m2a-magnum and C2a-taper)

Device

Sponsors and collaborators

Lead sponsor

Frederiksberg University Hospital

Other

Registry information

Important dates

Study start: 2006
Primary completion: 2007
First posted: Feb 1, 2006
Registry last updated: Mar 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.